Towards consensus on practical probabilistic evaluation metrics for clinical decision making in radiotherapy
Jenneke I. de Jong, Steven J. M. Habraken, Erik W. Korevaar, Mirko Unipan, Esther Kneepkens, Gloria Vilches Freixas, Yvonne L. B. Klaver, Michiel Kroesen, Alejandra Méndez Romero, Edwin Oldehinkel, Stephanie Peeters, Roel J. H. M. Steenbakkers, Karolien Verhoeven, Stefan Both, Liesbeth J. Boersma, Sebastiaan Breedveld, Mischa S. Hoogeman
Abstract
Introduction: The main aim of this paper is to identify clinically feasible probabilistic evaluation approaches for radiotherapy and to assess whether they can support clinical decision making better than current robustness evaluation approaches. To this end, we calibrate probabilistic clinical goals and identify evaluation metrics with a team of medical physics experts and apply these to three patient cohorts. Methods: Sixty intensity-modulated proton therapy plans from three Dutch proton centers were included: 20 neuro-oncological, 20 head-and-neck, and 20 breast cancer cases. Probabilistic evaluation was performed using polynomial chaos expansion with 10,000 simulated fractionated treatments per case. Volumetric and dosimetric CTV goals were calibrated at a 90% probability level. Selected probabilistic evaluation metrics were applied to representative patient cases and eight radiation oncologists participated in semi-structured interviews addressing preferred metrics and probability levels. Results: The calibrated volumetric goals were V0.95Dpres = 99.95%, 99.80% and 99.54% at a 90% probability level for the neuro-oncological, head-and-neck, and breast cohorts, respectively. The dosimetric goals were D98%,CTV = 0.973Dpres, 0.968Dpres and 0.967Dpres at a 90% probability level. All radiation oncologists considered the probabilistic evaluation metrics suitable for clinical decision making, and most regarded them as an improvement over the currently used VWmin/max approach. Preferences for individual metrics and probability levels varied among radiation oncologists, centers and treatment sites. Conclusion: Probabilistic evaluation metrics are expected to be clinically usable and an improvement over current methods by the interviewed radiation oncologists. Further consensus and clinical validation are needed before widespread clinical implementation.
Create a lesson
Related papers
Unmyelinated axons alter the biological interpretation of MRI biomarkers of demyelination
Ali Abdollahzadeh, Ricardo Coronado-Leija, Elizabeth Chasen et al.
Impact-Based Analysis Method (IBAM) to evaluate the primary stability of the pedicle screw: A proof of concept
Julie Gabriel, Yvan Petit, Giuseppe Rosi et al.
Geometry-bridge flow matching for blind rigid-motion correction in head cone-beam CT
Sungho Yun, Seungryong Cho
The relationship between junctional zone, smooth muscle tone and intra-uterine pressure
Nicolas R. Chevalier, Emilie Huon, Julie Poujol et al.
A Soft Sponge-Pillar Electrode Platform for Motion-Tolerant Ambulatory EEG and Sleep Monitoring
Chansoo Kim, Weilun Li, Ryan Andersen et al.
Using an instrumented hammer to predict the lateral hinge fracture in high tibial osteotomy: A cadaveric study
Claire Bastard, Manon Bas-Dit Nugues, Giuseppe Rosi et al.